Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO
Investigators from the TRANSITION-T2D study join Diabetes Dialogue to discuss the study and implications for care. Video version: https://www.hcplive.com/view/diabetes-dialogue-transition-t2d
26m Aug 23, 2023
26m
Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD
W. Timothy Garvey, MD, sits down to discuss the results of SURMOUNT-2, the ongoing revolution of antiobesity medications, and why he is concerned over the growing prevalence of online weight loss clinics. Video version: https://www.hcplive.com/view/diabetes-dialogue-second-generation-obesity-medications-with-w-timothy-garvey-md
20m Aug 23, 2023
20m
Diabetes Dialogue: Improving Implementation of New Technology, with Cari Berget, RN, MPH
Hosts are joined by Cari Berget, RN, MPH, for a deep dive into her efforts to improve the implementation of the latest diabetes technologies in real-world settings through her role as a director of the PANTHER Program. Video version: https://www.hcplive.com/view/diabetes-dialogue-improving-implementation-of-new-technology-with-cari-berget-rn-mph
17m Aug 23, 2023
17m
Diabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes
Often overlooked and unrecognized, the mental health challenges accompanying type 1 diabetes are becoming a focal point of discussion for many in the field, including Mark Heyman, PhD, who joined Diana Isaacs, PharmD, and Natalie Bellini, DNP, for a special ADA 2023 edition of Diabetes Dialogue. Video version: https://www.hcplive.com/view/diabetes-dialogue-managing-addressing-mental-health-nee...
25m Aug 23, 2023
25m
Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD
At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to address shortfalls of the current language used in the management of diabetes. Video version: https://www.hcplive.com/view/diabetes-dialogue-reforming-language-in-metabolic-disease-with-jane-dickinson-rn-phd
17m Aug 23, 2023
17m
Diabetes Dialogue: Diabetic Foot Ulcers and Social Determinants of Health
At ADA 2023, hosts sit down with Gary Rothenberg, DPM, to discuss awareness and management of diabetic foot ulcers as well as how social determinants of health can influence risk and outcomes for patients with diabetes. Video version: https://www.hcplive.com/view/diabetes-dialogue-diabetic-foot-ulcers-and-social-determinants-of-health
19m Aug 23, 2023
19m
Diabetes Dialogue: What to Know about the iLet Bionic Pancreas
As a follow-up to an episode earlier this year and the FDA clearances of the technology that forms the iLet Bionic Pancreas, hosts sat down in the MJH Life Sciences studio for a special edition recording to explore the implications of the clearance, dispel misconceptions surrounding the system, and hypothesize about the future of this technology in people with diabetes.
21m May 26, 2023
21m
Diabetes Dialogue: Breaking Down AACE's New Type 2 Diabetes Management Algorithms
In this special edition episode, hosts sit down for an in-depth discussion surrounding the new management algorithms from the AACE and break down how they expect the new guidance to impact patient care.
24m May 18, 2023
24m
Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD
In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, including use, exclusive features, and how patients can obtain the new system.
34m May 12, 2023
34m
Diabetes Dialogue: SURMOUNT-2 Reaction, Omnipod GO, and Verapamil for T1D
In this episode, hosts offer their reaction to topline data from the SURMOUNT-2 trial examining tirzepatide for weight management in T2D, the FDA's clearance of the Omnipod GO device, and results of the CLVer trial.
31m May 03, 2023
31m
Diabetes Dialogue: CMS Expansion Ushers in New Age of CGM Access
In this in-studio episode, hosts offer insight and perspective into what the news regarding the CMS expansion of CGM coverage means for people with diabetes and take a deep dive into a recent announcement of an FDA clearance for Abbott's FreeStyle Libre sensors.
20m Mar 17, 2023
20m
Diabetes Dialogue: ATTD 2023 Recap
A recap of the top news and research from the 16th annual meeting for Advanced Technologies and Treatments for Diabetes in Berlin, Germany.
17m Mar 03, 2023
17m
Diabetes Dialogue: Practical Updates in Pediatric Diabetes, with Stuart Weinzimer, MD
In this episode, Stuart Weinzimer, MD sits down with hosts for a discussion on his research and experience with diabetes technology, the need to focus on patient-reported outcomes in pediatric diabetes, and strategies for meeting the practical needs of individuals with diabetes.
16m Mar 02, 2023
16m
Diabetes Dialogue: Technology Guidelines and Uptake in Diabetes, with Grazia Aleppo, MD
In this episode, hosts are joined by Grazia Aleppo, MD, to discuss the development of guideline recommendations for diabetes technology as well as her top takeaways from the ATTD 2023 meeting.
22m Mar 01, 2023
22m
Diabetes Dialogue: The Role of Patient Voice in Diabetes Management
In this episode, hosts are joined by Marissa Town, BSN, RN, and Renza Scibilia for a discussion centered around the role of the patient voice in diabetes management while on site at ATTD 2023.
19m Feb 28, 2023
19m
Diabetes Dialogue: Actualizing the Optimal Role of Inhaled Insulin, with Joanne Rinker, MS, RDN
In this episode, hosts are joined by the associate director of Medical Affairs and Medical Education at MannKind for a special edition episode from ATTD 23 that focuses on use of inhaled insulin and future research plans for MannKind.
10m Feb 28, 2023
10m
Diabetes Dialogue: Updates in Diabetes Management from ATTD 23, with Irl Hirsch, MD
In this episode, Irl Hirsch, MD, discusses a study he is conducting examining skin changes associated with insulin pump use in people with type 1 diabetes. Later in the episode, Hirsch discusses what he is most excited about in terms of ongoing and future research in diabetes management.
23m Feb 26, 2023
23m
Diabetes Dialogue: Screenings for Hearing Loss in Diabetes, with Joanne Rinker, MS, RDN
In this episode from ATTD 2023, hosts are joined by Joanne Rinker, MS, RDN, who provides perspective on hearing loss in diabetes, including prevalence, the need for screening, and the underrecognition of auditory issues in the midst of a growing population of people with diabetes.
8m Feb 25, 2023
8m
Diabetes Dialogue: Mental Health and PRO Standardization, with Katharine Barnard-Kelly, PhD
In this episode, hosts sit down with Katharine Barnard-Kelly, PhD, at ATTD 2023 to discuss the evolving recognition of the role of psychology in diabetes management for both pediatric and adult populations.
15m Feb 25, 2023
15m
Diabetes Dialogue: FDA Clearance of Tidepool Loop
In this episode of Diabetes Dialogue, ours hosts discuss the clearance of Tidepool Loop, what is unique about the app’s customizability and compatibility with other diabetes technologies, and other top points for people with diabetes and members of the diabetes care team to consider with the technology moving into the future. Check out the video version here.
17m Jan 30, 2023
17m
Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS
In their final episode from the ADCES 2nd Annual Diabetes Technology Conference, our hosts are joined by Gary Scheiner, MS, and Jennifer Okemah, RD, to discuss their businesses, a glimpse into their personal journeys into becoming diabetes care and education specialists, and how they have seen their role in improving care transform in recent years.
26m Jan 21, 2023
26m
Diabetes Dialogue: The Prospect of a Bionic Pancreas, with Steven Russell, MD, PhD
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Steven Russell, MD, PhD, the chief medical officer of Beta Bionics, for a discussion around his journey to becoming CMO as well as a deep dive into the iLet Bionic Pancreas and its potential in diabetes management.
31m Jan 14, 2023
31m
Diabetes Dialogue: December 2022
In the December 2022 episode, Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss recent developments in the field, with a spotlight on the Dexcom G7 CGM, key takeaways from the ADA’s Standards of Care in Diabetes—2023, and perspective from the ADCES Diabetes Technology Conference 2022.
33m Dec 23, 2022
33m
Diabetes Dialogue: The Psychology of Diabetes Management, with Jill Weissberg-Benchell, PhD
In this episode of Diabetes Dialogue, Jill Weissberg-Benchell, PhD, takes hosts through her journey to becoming a diabetes care and education specialist, the role of psychologists in the management of pediatric diabetes, and her thoughts on the evolving role of care and education specialists in the management of diabetes.
28m Dec 23, 2022
28m
Diabetes Dialogue: Updates in Inpatient Management of Diabetes, with Jane Jeffrie Seley, DNP, MPH
Jane Jeffrie Seley, DNP, MPH, a member of the writing committee for the ADA's Standards of Care in Diabetes—2023, joins the podcast to discuss pertinent updates in the sections of the document discussing inpatient management of diabetes within the document.
31m Dec 13, 2022
31m
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
Hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, break down what the approval of teplizumab means for type 1 diabetes. During the episode, hosts take a deep dive into type 1 diabetes staging and hypothesize around the role of CDCES in educating primary care and other specialties to optimize the potential of teplizumab.
27m Nov 17, 2022
27m
Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MD
In this episode, our hosts are joined by Lydia Alexander, MD, president-elect of the Obesity Medicine Association, to discuss the updates in the landscape of obesity management as well as a deep dive into the recent American Gastroenterological Association guidelines for pharmacological management and the OMA's annual meeting.
33m Nov 14, 2022
33m
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP,  discuss the ongoing GLP-1 RA shortage and whether or not celebrities using these agents for weight loss is a real issue in the community as well as provide insight into their top takeaways from the ADA/KDIGO consensus report.
29m Oct 24, 2022
29m
Diabetes Dialogue: EASD 2022 and Recent CGM News
In this special edition episode of Diabetes Dialogue, our hosts break down their top clinical takeaways from the European Association for the Study of Diabetes 2022 annual meeting, new data from the FLASH-UK trial, the global launch of Dexcom G7, and the announcement of US availability for the FreeStyle Libre 3.
34m Oct 13, 2022
34m
Diabetes Dialogue: September 2022
In the September 2022 episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives (https://www.endocrinologynetwork.com/diabetes-dialogue-podcast) , hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide their own perspective on DIY looping based on the results of a recent study published in the New England Journal of Medicine and also break down a new set of consen...
26m Oct 03, 2022
26m
Diabetes Dialogue: ADCES 2022 Recap
In this episode of Diabetes Dialogue, which was filmed days after the conclusion of ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the conference, their favorite sessions, and how ADCES meetings have evolved to the changing role of diabetes care and education specialists over the years.
30m Aug 24, 2022
30m
Diabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD
In this edition of Diabetes Dialogue, which was filmed on-site at ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with Jennifer Clements, PharmD, following her sessions to discuss her work, her upcoming research interests, and ongoing trends in the field of diabetes management. During her time at the meeting, Clements was the primary presenter for a trio of sessions foc...
16m Aug 17, 2022
16m
Diabetes Dialogue: Sit Down with Diabetes Care and Education Specialist of the Year, Anastasia Albanese-O'Neill, PhD
In this episode, the hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with ADCES 2022 Diabetes Care and Education Specialist of the Year Anastasia Albanese-O’Neill, PhD, to discuss her inspiration, her work within the field, and insight into the project she has decided to focus on during her year as ADCES Diabetes Care and Education Specialist of the Year.
21m Aug 15, 2022
21m
Diabetes Dialogue: T1D Exchange, with David Walton
In this ADCES 22 special edition episode of Diabetes Dialogue, our hosts are joined by David Walton, CEO of the T1D Exchange, who takes our hosts on a deep dive into the history of the organization, what it is doing right now to improve patient care, and how it expects to grow and improve management of type 1 diabetes into the future.
19m Aug 14, 2022
19m
Diabetes Dialogue: Exploring DiabetesWise, with Korey Hood, PhD
In this special edition of Diabetes Dialogue recorded on-site at ADCES 22, our hosts are joined by Korey Hood, PhD, a staff pscyhologist and professor at Stanford University. Founder of DiabetesWise and DiabetesWisePro, Hood talks to Diana Isaacs, PharmD, and Natalie Bellini, DNP, about his efforts and how the online resources are pushing care forward. More information on these sites can be fo...
19m Aug 14, 2022
19m
Diabetes Dialogue: The Race to Cure T1D
For the July 2022 episode of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to provide perspective on the latest advances in the fight to cure type 1 diabetes and offer insight into their experiences at the Practical Ways to Achieve Targets in Diabetes Care Conference held in Keystone, CO in mid-July.
26m Jul 29, 2022
26m
Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, & Misdiagnosis of T1D
In this episode, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss their experiences with prescribing tirzepatide (Mounjaro) and what issues patients have encountered, the prospect of new biosimilar insulins coming to the market, and the misdiagnosis of type 1 diabetes in adult patients.
24m Jun 24, 2022
24m
Diabetes Dialogue: Inside ADA 2022
In the fourth and final episode from ADA 2022, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the meeting from their perspectives as a clinical pharmacy specialist and a nurse practitioner, including their picks for the most exciting advances in diabetes technology to come from the year’s largest diabetes meeting.
21m Jun 10, 2022
21m
Diabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmD
In the third special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, Dr. Jasmine Gonzalvo, director of the Center for Health Equity and Innovation at the Purdue University College of Pharmacy, joins hosts Drs. Diana Isaacs and Natalie Bellini to discuss prevailing barriers in diabetes management, including access to new pharmacologic agen...
11m Jun 09, 2022
11m
Diabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE
In our second special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, hosts Drs. Diana Isaacs and Natalie Bellini are joined by Gary Scheiner, MS, CDE. Clinical director of Integrated Diabetes Services, author of multiple books, including Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin, and former Diabetes Educa...
17m Jun 09, 2022
17m
Diabetes Dialogue: Optimizing CGM Uptake in Primary Care
In the first of 4 special edition ADA 2022 episodes, hosts Drs. Diana Isaacs and Natalie Bellini take on the role of interviewers and discuss CGM uptake in primary care with Drs. Sean and Tamara Oser. Later in the episode, the pair provide perspective on their experiences with Beta Bionics's Insulin-Only Bionic Pancreas.
20m Jun 07, 2022
20m
Diabetes Dialogue: Tirzepatide in Action & AACE 2022 Recap
In this episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into what the tirzepatide (Mounjaro) approval, including discussions around the mechanism of action for the first-in-class agent, dose titrations, and where it might fit in the upcoming ADA standards of care. Later in the episode, host...
22m May 20, 2022
22m
Diabetes Dialogue: ATTD 2022 Recap
In this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, provide insight into their favorite sessions from the conference and clinical pearls they took away from their experience, including latest updates in the world of diabetes smart phon...
21m May 06, 2022
21m
Diabetes Dialogue: April 2022
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of semaglutide 2.0 mg (Ozempic)'s approval, the use of novel glycemic control metrics, and a preview of ATTD 2022.
19m Apr 28, 2022
19m
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
The inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, and a discussion around recent regulatory news surrounding CGM devices in the US and Europe.  
23m Mar 30, 2022
23m
Semaglutide 2.4 mg (Wegovy):A Turning Point for Obesity
Ahead of ADA 2021, Dr. Thomas Wadden discusses the significance of the Wegovy approval for chronic weight management and Novo Nordisk's plans to evaluate an oral version. 
16m Jun 25, 2021
16m
Subcutaneous Semaglutide for Weight Loss with Thomas Wadden, PhD
This episode of the Endocrine Outlook podcast features Thomas Wadden, PhD, a professor of psychology at Perelman School of Medicine at the University of Penn. Wadden is also a principal investigator in the STEP Program, which is a series of clinical trials funded by Novo Nordisk examining subcutaneous semaglutide for inducing weight loss in patients who are obese or overweight.  During this ep...
24m Mar 16, 2021
24m
Tirzepatide for Weight Loss and Lowering HbA1c with Juan Frias, MD
This episode of the Endocrine Outlook features a conversation with Juan Frias, MD, medical director of the National Research Institute. Frias is also the principal investigator of the SURPASS-2 trial which examined Eli Lilly’s Dual GLP1/GIP agonist tirzepatide against 1mg semaglutide for glucose control and weight loss in patients with diabetes. 
21m Mar 15, 2021
21m
Dietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP
In this episode, Endocrinology Network senior editor Patrick Campbell speaks with Dr. Ariana Chao, of Penn Nursing, about dietary interventions and nutrition. Chao is the lead author of a recent study examining these topics published in the Journal of Clinical Investigation.
18m Feb 17, 2021
18m
Jeffrey Curtis, MD: Osteoporosis in 2020
This episode of the Endocrine Outlook features a  recent interview with Dr. Jeffrey Curtis, of the University of Alabama at Birmingham. A rheumatologist and leading expert in osteoporosis research, Curtis and I have a lengthy discussion around osteoporosis and challenges in treating the disease, the impact of the COVID-19 pandemic, and one of the most unrecognized problems in rheumatology: the ...
21m Dec 07, 2020
21m